Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antepartum Etonogestrel Implant Insertion
NCT03656289Phase 1Withdrawn
- Sponsor
- University of Colorado Denver
- Start
- Jan 2019
- Primary completion
- Apr 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of etonogestrel in unintended pregnancy, sponsored by University of Colorado Denver. Primary endpoint: Maternal and cord blood serum etonogestrel concentration. Planned start Jan 2019; status: withdrawn.
02
Drugs
etonogestrel
03
Conditions
unintended pregnancy
Beyond the preview
Go deeper on NCT03656289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03656289.